Skip to main content
Erschienen in: World Journal of Surgical Oncology 1/2012

Open Access 01.12.2012 | Case report

Cutaneous leiomyosarcoma arising in a smallpox scar

verfasst von: Robert A Pol, Hilde Dannenberg, Jan-Lukas Robertus, Robert J van Ginkel

Erschienen in: World Journal of Surgical Oncology | Ausgabe 1/2012

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Background

Cutaneous leiomyosarcoma (CLM) is a very rare smooth muscle tumour that accounts for about 2–3% of all superficial soft tissue sarcomas. Although the development of various malignancies in scar tissue is well known, we report the first case of a CLM developing in a small pox scar.

Case presentation

A 66-year-old man presented with a painless, slow-growing lump in a small pox scar on his left shoulder. Histological biopsies showed the lesion to be a primary, well-differentiated cutaneous leiomyosarcoma. A CT scan of the thorax was conducted, which showed no signs of metastases. The complete lesion was then surgically excised, and histopathological examination revealed a radically excised cutaneous type leiomyosarcoma After 13 months’ review the patient was doing well with no evidence of tumour recurrence.

Conclusions

This is the first report of a CLM arising in a small pox scar. Although the extended time interval between scarring and malignant changes makes it difficult to advise strict follow-up for patients with small pox scars, one should be aware that atypical changes and/or symptoms occurring in a small pox scar could potentially mean malignant transformation.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1477-7819-10-148) contains supplementary material, which is available to authorized users.

Competing interests

The authors declare that they have no competing interest.

Authors’ contributions

RP and HD drafted the manuscript. JLR drafted part of the manuscript, critically revised its final form, and provided Figures 2 and 3. RJG critically revised the final manuscript and was responsible for the primary care and outpatient controls. All authors read and approved the final manuscript.

Background

Cutaneous leiomyosarcoma (CLM) is a very rare smooth muscle tumour that accounts for about 2–3% of all superficial soft tissue sarcomas [1]. CLM presents in persons of all ages but with a peak occurrence between 50–70 years of age. It may occur anywhere on the body with a predilection for the limbs. Clinical appearance of CLM is non-specific with a wide range of differential diagnoses including squamous cell carcinoma, amelanotic melanoma and basal cell carcinoma [2]. Although the development of various malignancies in scar tissue is well known, the highest association is found in chronic burn scars. However, sarcomas develop very rarely in (burn) scars. A case of a CLM developing in a small pox scar is presented. To our knowledge, this is the first report of such an association.

Case presentation

A 66-year-old man was referred to our outpatient clinic by his dermatologist. He presented with a painless, slow-growing lump in a small pox scar on his left shoulder (Figure 1). Histological biopsies were taken and reviewed by a specialised panel for soft tissue tumours, which showed the lesion to be a primary, well-differentiated cutaneous leiomyosarcoma. On re-examination, a firm, nodular scar was seen with no signs of ulceration. There was no lymphadenopathy in his axilla and/or neck. Additionally, a CT scan of the thorax was conducted, which showed no signs of metastases. The complete lesion was then surgically excised and submitted for further pathological examination (Figures 2 and 3). Histopathological examination revealed a poorly delineated tumour located in the dermis with nodular extension into the superficial subcutis and showing a fasciculated growth pattern of spindle cells with eosinophilic cytoplasm and hyperchromatic, elongated, blunt-ended and pleomorphic nuclei. The mitotic index was less than 10/7 HPF (1.7 mm). Neoplastic cells showed reactivity to α-smooth muscle actin and desmin (Figure 4).
No necrosis was found. Clear surgical margins (> 5 mm) were confirmed histologically. In conclusion, it concerned a radically excised cutaneous type leiomyosarcoma, Coindre type 1. At 13-month review, the patient was doing well with no evidence of tumour recurrence. A control chest x-ray after 6 and 12 months showed no evidence of metastases.

Discussion

CLM are very rare tumours. They typically present with skin changes such as discolouration and ulceration, and are generally small at presentation (1–2 cm). Due to their low incidence and atypical presentation, they are often misdiagnosed. The most effective treatment of CLM is wide excision with a 3-5-cm lateral margin and a depth that includes the subcutaneous tissue and fascia [3, 4]. Local excision without adequate margins leads to recurrence, and increases the risk for metastatic and possibly fatal disease.
Leiomyosarcoma of the skin can be classified as either superficial (cutaneous or subcutaneous) or metastatic leiomyosarcoma from a distant visceral site such as the uterus or retroperitoneum [2]. Differentiation between the cutaneous and subcutaneous subtypes is not always straightforward, and the distinction is made on the basis of different histological features and biological behaviour [5]. As in our patient, CLM occurs most often on the extremities [6]. The metastatic potential differs significantly between the histological subtypes, with the cutaneous variant having a very low rate of distant metastasis and a local recurrence rate of 30% [3]. In this specific case, it also concerned a CLM and, because of the clear surgical margins, has an excellent prognosis.
The aetiology of these tumours is relatively unknown, although antecedent traumatic injury, ionising irradiation, chemicals, sunlight and lupus vulgaris have been associated with this type of tumour [7]. We here describe the first patient with CLM arising in a small pox scar. There are various reports on CLM with a similar association with scars [79]. The most common association, however, is found in burn scars. The pathogenesis of malignant transformation in burn scars is not known, mainly because of the low incidence with only 11 cases reported in the literature [9].
Besides the occasional occurrence of CLM, a familial occurrence of cutaneous leiomyosarcoma with renal cancer has been described in the context of hereditary cutaneous leiomyomatosis and renal cell cancer (HLRCC) [10, 11]. This rare inherited tumour syndrome is caused by germ line mutations in the fumarate hydratase (FH) gene [12]. However, mutations in FH do not explain sporadic CLM formation in scar tissue, since aberrant FH expression or somatic mutations are not seen in sporadic tumours [13, 14]. Adjuvant therapies include radiation therapy, chemotherapy and super voltage cobalt therapy, although CLM has been reported to be both radio- and chemotherapy resistant. [15]
Because this is the first report of a CLM arising in a small pox scar, the presence of a common pathway to malignant transformation with burn scars cannot be determined. Although only a few risk factors have been identified, the most obvious relation with scar tissue has to be the antecedent traumatic injury. The extended time interval between scarring and malignant changes makes it difficult to advise strict follow-up for patients with small pox scars. One should be aware however that atypical changes and/or symptoms occurring in a small pox scar could potentially mean malignant transformation, and adequate diagnostic procedures such as local biopsy and/or primary/secondary wide local excision are the first appropriate steps.

Conclusions

This report describes the first case of CLM formation in a small pox scar. Primary CLM can be a diagnostic challenge and adequate surgical excision is the appropriate treatment. Based on this one case, regular checks cannot be recommended. However, any change in the existing scar should be followed by a biopsy in order to exclude a sarcoma or make an early diagnosis.
Written informed consent was obtained from the patient for publication of this report and accompanying images. A copy of this written consent is available for review by the Editor-in-Chief of this journal.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Competing interests

The authors declare that they have no competing interest.

Authors’ contributions

RP and HD drafted the manuscript. JLR drafted part of the manuscript, critically revised its final form, and provided Figures 2 and 3. RJG critically revised the final manuscript and was responsible for the primary care and outpatient controls. All authors read and approved the final manuscript.
Anhänge

Authors’ original submitted files for images

Literatur
1.
Zurück zum Zitat Zahm SH, Fraumeni JF: The epidemiology of soft tissue sarcoma. Semin Oncol. 1997, 24: 504-512.PubMed Zahm SH, Fraumeni JF: The epidemiology of soft tissue sarcoma. Semin Oncol. 1997, 24: 504-512.PubMed
2.
Zurück zum Zitat Annest NM, Grekin SJ, Stone MS, Messingham MJ: Cutaneous leiomyosarcoma: a tumour of he head and neck. Dermatol Surg. 2007, 33: 628-633. 10.1111/j.1524-4725.2007.33124.x.PubMed Annest NM, Grekin SJ, Stone MS, Messingham MJ: Cutaneous leiomyosarcoma: a tumour of he head and neck. Dermatol Surg. 2007, 33: 628-633. 10.1111/j.1524-4725.2007.33124.x.PubMed
3.
Zurück zum Zitat Kuflik JH, Schwartz RA, Rothenberg J: Dermal leiomyosarcoma. J Am Acad Dermatol. 2003, 48: S51-S53. 10.1067/mjd.2003.234.CrossRefPubMed Kuflik JH, Schwartz RA, Rothenberg J: Dermal leiomyosarcoma. J Am Acad Dermatol. 2003, 48: S51-S53. 10.1067/mjd.2003.234.CrossRefPubMed
4.
Zurück zum Zitat Angeloni M, Muratori F, Magarelli N, Chalidis BE, Ricci R, Rossi B, Maccauro G: Exophytic growth of a neglected giant subcutaneous leiomyosarcoma of the lower extremity. A case report. Int Semin Surg Oncol. 2008, 5: 11-10.1186/1477-7800-5-11.PubMedCentralCrossRefPubMed Angeloni M, Muratori F, Magarelli N, Chalidis BE, Ricci R, Rossi B, Maccauro G: Exophytic growth of a neglected giant subcutaneous leiomyosarcoma of the lower extremity. A case report. Int Semin Surg Oncol. 2008, 5: 11-10.1186/1477-7800-5-11.PubMedCentralCrossRefPubMed
5.
Zurück zum Zitat Bernstein SC, Rienigk RK: Leiomyosarcoma of the skin. Treatment of 34 cases. Dermatol Surg. 1996, 22: 631-635.PubMed Bernstein SC, Rienigk RK: Leiomyosarcoma of the skin. Treatment of 34 cases. Dermatol Surg. 1996, 22: 631-635.PubMed
6.
Zurück zum Zitat Liao WC, Lin JT, Ma H, Chen WYK, Yeh FL: Primary cutaneous leiomyosarcoma. J Plast Surg Assoc ROC. 2003, 12 (1): 1-10. Liao WC, Lin JT, Ma H, Chen WYK, Yeh FL: Primary cutaneous leiomyosarcoma. J Plast Surg Assoc ROC. 2003, 12 (1): 1-10.
7.
Zurück zum Zitat Gonzales-Sixto B, De la Torre C, Parvadilla R, Carpintero ML: Leiomyosarcoma arising from scofuloderma scar. Clin Exp Dermatol. 2008, 33: 776-778.CrossRef Gonzales-Sixto B, De la Torre C, Parvadilla R, Carpintero ML: Leiomyosarcoma arising from scofuloderma scar. Clin Exp Dermatol. 2008, 33: 776-778.CrossRef
8.
Zurück zum Zitat Conzales-Vela MC, Val=Bernal JF, Rubio S, Olalla JJ, Gonzales-Lopez MA: Cutaneous leiomyosarcoma developing on a pacemaker pocket. Dermatol Surg. 2009, 35: 863-867. 10.1111/j.1524-4725.2009.01145.x.CrossRef Conzales-Vela MC, Val=Bernal JF, Rubio S, Olalla JJ, Gonzales-Lopez MA: Cutaneous leiomyosarcoma developing on a pacemaker pocket. Dermatol Surg. 2009, 35: 863-867. 10.1111/j.1524-4725.2009.01145.x.CrossRef
9.
Zurück zum Zitat Can Z, Yilmaz S, Riza A, Erocen , Apaydin I, Kuzu I: Sarcoma developing in a burn scar: case report and review of the literature. Burns. 1998, 24: 68-71. 10.1016/S0305-4179(97)00091-0.CrossRefPubMed Can Z, Yilmaz S, Riza A, Erocen , Apaydin I, Kuzu I: Sarcoma developing in a burn scar: case report and review of the literature. Burns. 1998, 24: 68-71. 10.1016/S0305-4179(97)00091-0.CrossRefPubMed
10.
Zurück zum Zitat Toro JR, Nickerson ML, Wei MH, Warren MB, Glenn GM, Turner ML, Stewart L, Duray P, Tourre O, Sharma N, Choyke P, Stratton P, Merino M, Walther MM, Linehan WM, Schmidt LS, Zbar B: Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet. 2003, 73: 95-106. 10.1086/376435.PubMedCentralCrossRefPubMed Toro JR, Nickerson ML, Wei MH, Warren MB, Glenn GM, Turner ML, Stewart L, Duray P, Tourre O, Sharma N, Choyke P, Stratton P, Merino M, Walther MM, Linehan WM, Schmidt LS, Zbar B: Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet. 2003, 73: 95-106. 10.1086/376435.PubMedCentralCrossRefPubMed
11.
Zurück zum Zitat Wei MH, Toure O, Glenn GM, Pithukpakorn M, Neckers L, Stolle C, Choyke P, Grubb R, Middelton L, Turner ML, Walther MM, Merino MJ, Zbar B, Linehan WM, Toro JR: Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet. 2006, 43: 18-27.PubMedCentralCrossRefPubMed Wei MH, Toure O, Glenn GM, Pithukpakorn M, Neckers L, Stolle C, Choyke P, Grubb R, Middelton L, Turner ML, Walther MM, Merino MJ, Zbar B, Linehan WM, Toro JR: Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet. 2006, 43: 18-27.PubMedCentralCrossRefPubMed
12.
Zurück zum Zitat Tomlinson IP, Alam NA, Rowan AJ, Barclay E, Jaeger EE, Kelsell D, Leigh I, Gorman P, Lamlum H, Rahman S, Roylance RR, Olpin S, Bevan S, Barker K, Hearle N, Houlston RS, Kiuru M, Lehtonen R, Karhu A, Vilkki S, Laiho P, Eklund C, Vierimaa O, Aittomäki K, Hietala M, Sistonen P, Paetau A, Salovaara R, Herva R, Launonen V: Germ line mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet. 2002, 30: 406-410. 10.1038/ng849.CrossRefPubMed Tomlinson IP, Alam NA, Rowan AJ, Barclay E, Jaeger EE, Kelsell D, Leigh I, Gorman P, Lamlum H, Rahman S, Roylance RR, Olpin S, Bevan S, Barker K, Hearle N, Houlston RS, Kiuru M, Lehtonen R, Karhu A, Vilkki S, Laiho P, Eklund C, Vierimaa O, Aittomäki K, Hietala M, Sistonen P, Paetau A, Salovaara R, Herva R, Launonen V: Germ line mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet. 2002, 30: 406-410. 10.1038/ng849.CrossRefPubMed
13.
Zurück zum Zitat Barker KT, Spendlove HE, Banu NS, Bridge JA, Fisher C, Shipley J, Garrett M, Manyonda I, Houlston RS: No evidence for epigenetic inactivation of fumarate hydratase in leiomyomas and leiomyosarcomas. Cancer Lett. 2006, 235: 136-140. 10.1016/j.canlet.2005.04.017.CrossRefPubMed Barker KT, Spendlove HE, Banu NS, Bridge JA, Fisher C, Shipley J, Garrett M, Manyonda I, Houlston RS: No evidence for epigenetic inactivation of fumarate hydratase in leiomyomas and leiomyosarcomas. Cancer Lett. 2006, 235: 136-140. 10.1016/j.canlet.2005.04.017.CrossRefPubMed
14.
Zurück zum Zitat Barker KT, Bevan S, Wang R, Lu YJ, Flanagan AM, Bridge JA: Low frequency of somatic mutations in the FH/multiple cutaneous leiomyomatosis gene in sporadic leiomyosarcomas and uterine leiomyomas. Br J Cancer. 2002, 87 (4): 446-448. 10.1038/sj.bjc.6600502.PubMedCentralCrossRefPubMed Barker KT, Bevan S, Wang R, Lu YJ, Flanagan AM, Bridge JA: Low frequency of somatic mutations in the FH/multiple cutaneous leiomyomatosis gene in sporadic leiomyosarcomas and uterine leiomyomas. Br J Cancer. 2002, 87 (4): 446-448. 10.1038/sj.bjc.6600502.PubMedCentralCrossRefPubMed
15.
Zurück zum Zitat Lin JY, Tsai RY: Subcutaneous leiomyosarcoma on the face. Dermatol Surg. 1999, 25: 489-491. 10.1046/j.1524-4725.1999.08290.x.CrossRefPubMed Lin JY, Tsai RY: Subcutaneous leiomyosarcoma on the face. Dermatol Surg. 1999, 25: 489-491. 10.1046/j.1524-4725.1999.08290.x.CrossRefPubMed
Metadaten
Titel
Cutaneous leiomyosarcoma arising in a smallpox scar
verfasst von
Robert A Pol
Hilde Dannenberg
Jan-Lukas Robertus
Robert J van Ginkel
Publikationsdatum
01.12.2012
Verlag
BioMed Central
Erschienen in
World Journal of Surgical Oncology / Ausgabe 1/2012
Elektronische ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-10-148

Weitere Artikel der Ausgabe 1/2012

World Journal of Surgical Oncology 1/2012 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.